New prognostic biomarkers for oesophageal adenocarcinoma (OAC) may help treatment planning as current staging does not accurately predict survival for many patients. We used a 451 cancer-associated gene panel to assess genomic alterations associated with survival for a cohort of 65 OAC patients who underwent surgical resection without perioperative treatment, reflecting institutional practice at the time. Median age at operation was 72 years, 88% were male, median 32 lymph nodes were removed per patient, and minimum follow-up exceeded 11 years.
Genomic correlates with survival after treatment of oesophageal adenocarcinoma by surgery alone
calendar_today
October 16, 2026
person
Trinh, A., Udumanne, T. P., Lord, S. J., Falkenback, D., Levert-Mignon, A. J., Liew, Y. J., Pascovici, D., Bourke, M. J., Grady, J. P., McCabe, M., Naeini, M. M., Joshua, A., Barnet, M., Goldstein, L. D., Ross, J., Johansson, J., Lord, R. V.
domain
medrxiv